Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 22882727)

1.

CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.

Jiang XY, Zhang Q, Chen P, Li SY, Zhang NN, Chen XD, Wang GC, Wang HB, Zhuang MQ, Lu M.

J Clin Pharm Ther. 2012 Dec;37(6):719-23. doi: 10.1111/j.1365-2710.2012.01372.x. Epub 2012 Aug 8.

PMID:
22882727
2.

CYP7A1 gene polymorphism located in the 5' upstream region modifies the risk of coronary artery disease.

Iwanicki T, Balcerzyk A, Niemiec P, Nowak T, Ochalska-Tyka A, Krauze J, Kosiorz-Gorczynska S, Grzeszczak W, Zak I.

Dis Markers. 2015;2015:185969. doi: 10.1155/2015/185969. Epub 2015 Apr 6.

3.

APOE polymorphisms contribute to reduced atorvastatin response in Chilean Amerindian subjects.

Lagos J, Zambrano T, Rosales A, Salazar LA.

Int J Mol Sci. 2015 Apr 9;16(4):7890-9. doi: 10.3390/ijms16047890.

4.

POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia.

Drogari E, Ragia G, Mollaki V, Elens L, Van Schaik RH, Manolopoulos VG.

Pharmacogenomics. 2014 Dec;15(16):1963-72. doi: 10.2217/pgs.14.138.

PMID:
25521355
5.

The role of common variants of ABCB1 and CYP7A1 genes in serum lipid levels and lipid-lowering efficacy of statin treatment: a meta-analysis.

Li Q, Hong J, Wu J, Huang ZX, Li QJ, Yin RX, Lin QZ, Wang F.

J Clin Lipidol. 2014 Nov-Dec;8(6):618-29. doi: 10.1016/j.jacl.2014.07.010. Epub 2014 Aug 7.

PMID:
25499945
6.

Relationship between CYP7A1 -204A>C polymorphism with gallbladder stone disease and serum lipid levels: a meta-analysis.

Cai Q, Wang ZQ, Cai Q, Li C, Chen EZ, Jiang ZY.

Lipids Health Dis. 2014 Aug 8;13:126. doi: 10.1186/1476-511X-13-126.

7.

Influence of SREBP-2 and SCAP gene polymorphisms on lipid-lowering response to atorvastatin in a cohort of Chilean subjects with Amerindian background.

Lagos J, Zambrano T, Rosales A, Salazar LA.

Mol Diagn Ther. 2014 Aug;18(4):435-43. doi: 10.1007/s40291-014-0094-3.

PMID:
24615250
8.

Lack of association of the p450 oxidoreductase *28 single nucleotide polymorphism with the lipid-lowering effect of statins in hypercholesterolemic patients.

Ragia G, Kolovou V, Tavridou A, Elens L, Tselepis AD, Elisaf M, Van Schaik RH, Kolovou G, Manolopoulos VG.

Mol Diagn Ther. 2014 Jun;18(3):323-31. doi: 10.1007/s40291-013-0082-z.

PMID:
24430948
9.

Hepatitis B virus reactivation associated with atorvastatin.

Wu du C.

Int J Infect Dis. 2013 Nov;17(11):e1069-70. doi: 10.1016/j.ijid.2013.04.001. Epub 2013 May 30.

10.

Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients.

Willrich MA, Rodrigues AC, Cerda A, Genvigir FD, Arazi SS, Dorea EL, Bernik MM, Bertolami MC, Faludi A, Largura A, Baudhuin LM, Bryant SC, Hirata MH, Hirata RD.

Clin Chim Acta. 2013 Jun 5;421:157-63. doi: 10.1016/j.cca.2013.03.007. Epub 2013 Mar 15.

11.

Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.

Fu Q, Li YP, Gao Y, Yang SH, Lu PQ, Jia M, Zhang LR.

Eur J Clin Pharmacol. 2013 Jun;69(6):1269-74. doi: 10.1007/s00228-012-1453-9. Epub 2012 Dec 22.

PMID:
23263738
12.

Associations between the genotypes and phenotype of CYP3A and the lipid response to simvastatin in Chinese patients with hypercholesterolemia.

Hu M, Mak VW, Xiao Y, Tomlinson B.

Pharmacogenomics. 2013 Jan;14(1):25-34. doi: 10.2217/pgs.12.181.

PMID:
23252946
13.

Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response.

Rodrigues AC, Sobrino B, Genvigir FD, Willrich MA, Arazi SS, Dorea EL, Bernik MM, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RD.

Clin Chim Acta. 2013 Feb 18;417:8-11. doi: 10.1016/j.cca.2012.11.028. Epub 2012 Dec 13.

PMID:
23247049
14.

Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy.

Hubacek JA, Dlouha D, Adámkova V, Lanska V, Ceska R, Vrablik M.

Neuro Endocrinol Lett. 2012;33 Suppl 2:22-5.

PMID:
23183505
15.

Comments on "CYP3AP1*3 allele is associated with lipid-lowering efficacy of simvastatin and atorvastatin in Chinese women".

Hu M, Mak VW, Tomlinson B.

J Clin Pharmacol. 2012 Nov;52(11):1768-9; author reply 1770-1. doi: 10.1177/0091270011415411. No abstract available.

PMID:
23105125
16.

Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):349-54. doi: 10.2165/11632570-000000000-00000.

PMID:
22900989
17.

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).

Deshmukh HA, Colhoun HM, Johnson T, McKeigue PM, Betteridge DJ, Durrington PN, Fuller JH, Livingstone S, Charlton-Menys V, Neil A, Poulter N, Sever P, Shields DC, Stanton AV, Chatterjee A, Hyde C, Calle RA, Demicco DA, Trompet S, Postmus I, Ford I, Jukema JW, Caulfield M, Hitman GA; CARDS, ASCOT, and PROSPER Investigators.

J Lipid Res. 2012 May;53(5):1000-11. doi: 10.1194/jlr.P021113. Epub 2012 Feb 24.

18.

Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males.

Khosropanah I, Falahatkar S, Farhat B, Heidari Bateni Z, Enshaei A, Allahkhah AA, Khosropanah D.

Acta Med Iran. 2011;49(12):789-94.

19.

Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.

Rosales A, Alvear M, Cuevas A, Saavedra N, Zambrano T, Salazar LA.

Clin Chim Acta. 2012 Feb 18;413(3-4):495-501. doi: 10.1016/j.cca.2011.11.003. Epub 2011 Nov 19.

PMID:
22120734
20.

The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.

Shen J, Arnett DK, Parnell LD, Lai CQ, Straka RJ, Hopkins PN, An P, Feitosa MF, Ordovás JM.

J Cardiovasc Pharmacol. 2012 Mar;59(3):254-9. doi: 10.1097/FJC.0b013e31823de86b.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk